Content continues after advertisement

Research Note: Estradiol Effect on Bone-Marrow–Derived Mesenchymal Stem Cells


|November 2018

Sign in to Print/View PDF

Fracture nonunion increases patient morbidity and healthcare costs. Bone grafts are often used in these defects but have several drawbacks. Bone-marrow–derived mesenchymal stem cells (BMSCs) may be an appealing alternative due to their trophic properties and immune-suppression function. 17β-estradiol has been shown to improve the osteogenesis and proliferation potential of mesenchymal stem cells in humans. This study evaluated the effect of 17β-estradiol on exploiting autologous BMSCs for healing of radial nonunion segmental defects in 20 rabbits. Through serial radiologic assessment and histopathologic evaluation, 17β-estradiol was found to provide BMSCs with improved osteogenic capacity and an accelerated rate of bone healing.


For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.


Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2023 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy